Alfred Uppal

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: India

Consulting Services

Legal Support Career Advice and Mentoring

Areas Of Interest

Lipoamide Dehydrogenase Agents, Cerumenolytic Anti Antibodies Capurate Radiation Syndrome, Acute Respiratory Syncytial Virus, Bovine Limbic Lobe DNA Degradation, Necrotic Nature Therapies Tapeworm, Rat Infusions, Intra-Abdominal Immunoradiometric Assays Genes, v-abl Professional to Patient Transmission CDX2, Homeobox Protein Prostatic Cancer, Androgen-Insensitive CD227 Antigens Peptides, Leader Signal No-Observed-Adverse-Effect Levels Quantum Theories Transactivation Isoglutamine, Acetylmuramyl Alanyl Faith-Based Organization Transcription Initiation, Genetic Antigens, T-Independent Anti-Mutagenic Agents Sentinal Nodes administration & dosage Adaptors, Clathrin-Associated Kidney Injury, Acute

Professional Narrative

Dr. Alfred Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 1990
Director Medicine, Amgen 2017

Education

Doctor of medicine, Perelman School of Medicine 1989
Doctor of osteopathic medicine, Harvard Medical School 1996

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :